01
Cash & equivalents increased 8.3%
Cash & equivalents changed +8.3% from the comparable as-filed period.
$10.5M→$11.3MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTMarker Therapeutics, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +8.3% from the comparable as-filed period.
Net income changed +54.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +38.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
MRKR · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-097262SEC ↗10-QMay 15, 2026Period Mar 31, 20260001104659-26-062763SEC ↗8-KMay 4, 2026Period May 1, 20260001104659-26-054940SEC ↗8-KMar 19, 2026Period Mar 18, 20260001104659-26-031309SEC ↗10-KMar 18, 2026Period Dec 31, 20250001104659-26-031274SEC ↗8-KFeb 9, 2026Period Feb 9, 20260001104659-26-012063SEC ↗4Nov 19, 2025Period Nov 17, 20250001768011-25-000003SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -64.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +1298.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001270905-25-000003